Docosahexaenoic Acid Supplementation And Cognitive Decline In Alzheimer Disease: A Randomized Trial
Notes for this study:
|Number of Subjects
2,000mg DHA from algae for 18 months failed to significantly delay symptoms associated with Alzheimer's disease or reduce the rate of cognitive decline as assessed by CDR and ADAS-cog rating scales. Similarly, the rate of brain atrophy was not affected.